Ad-Express and Daily Iowegian, Centerville, IA

Community News Network

March 26, 2014

8 million people take prescription sleep aids, but these drugs have risks

Insomnia. "It's a lifestyle thing; everybody's got it," says Gregg Jacobs, an insomnia specialist at the Sleep Disorders Center at the University of Massachusetts Medical School. More than half of American adults, when asked, report that they suffer from insomnia symptoms — trouble falling asleep or waking up during the night — a few times a week, according to the National Sleep Foundation.

About 8 million adults turn to prescription sleeping pills for help every month, according to a study published last year by the Centers for Disease Control and Prevention. And yet, Jacobs warns, these medications all have flaws.

Popular prescription medications for insomnia include the so-called Z-drugs: Ambien (zolpidem), Lunesta (eszopiclone) and Sonata (zaleplon). These drugs have shorter durations of action than older drugs such as the benzodiazepine Dalmane (flurazepam). That means they may help you fall asleep, but their effects don't last very long. They also are less likely to lead to morning grogginess.

And yet, recent data show that even the Z-drugs can cause problems. Last year, the FDA recommended that prescribed doses of Ambien be lowered, particularly for women. This came after reports of lingering effects in the morning, including drowsiness and impaired driving.

There are concerns with the Z-drugs in elderly people as well, with persisting effects causing daytime confusion, memory problems and falls, Jacobs says. In fact, the American Geriatric Society, which publishes a list of medications that the elderly should avoid because their side effects outweigh their benefits, recently discouraged the use of Z-drugs for any period longer than 90 days. Benzodiazepines when taken for insomnia are on the list as well.

The Z-drugs have similar effects on the brain as Dalmane and other benzodiazepines such as Klonopin and Halcion. These drugs act on GABA receptors, inhibiting neuronal function and thus tending to dampen many brain functions, including a wakeful state. The Z-drugs, thought to interact with a smaller subset of GABA receptors than the benzodiazepines, were hoped to produce fewer side effects than those drugs. However, many studies have found little difference between them. Other drugs are prescribed for sleep, such as certain antidepressants (Desyrel and Sinequan) that tweak the balance of brain chemicals involved in mood and alertness, and the melatonin-mimicking drug Rozerem (ramelteon), which delivers sleepytime signals to the brain.

"It's important to pick the right medicine to match your problem," Thomas Roth, a sleep medicine researcher at the Henry Ford Hospital in Detroit, says. It's equally important to know that there's a non-drug alternative.

Indeed, cognitive behavioral therapy, which includes using relaxation techniques, controlling stimulation before bedtime and reframing how people think about their sleep needs, may work better than any pill. Ten years ago, Jacobs published a study that found cognitive behavioral therapy superior to Ambien, producing bigger effects in falling asleep time and in overall sleep-vs.-wakeful time in bed.

Behavioral treatment and Ambien in combination did not produce any greater effect than behavioral treatment alone.

If you do go the medicine route, understand that drugs' sleep-inducing effects are limited and side effects may make them not worth your while.

A review of clinical trials found that, on average, people taking Z-drugs fall asleep 22 minutes sooner than those taking a placebo pill. But these drugs don't last very long, so they don't help keep you asleep in the pre-alarm clock hours.

Short-term side effects can include:

— Hangovers, "especially if you're sensitive or slow to metabolize the drugs," Roth says. For instance, women typically metabolize Ambien more slowly than men.

— Amnesia. This may be why people report better sleep when they take the drugs, Jacobs says: They don't remember being awake even if they were.

— Abnormal behavior, such as sleep driving or sleep eating. This effect is rare, Roth says, and is associated with taking a higher than recommended dose, combining the medication with alcohol or taking it more than a hour before bedtime. "Take your meds and go to bed," he says.

— Abuse and addiction. "The risk is very small except in vulnerable people," Roth says. People with addiction or alcohol abuse history are at much greater risk of using sleeping pills to get high.

If you have taken the drug long term (beyond a month or three), side effects may include:

— Dependence. After months of nightly use, your body can get so used to the drug that stopping suddenly can cause withdrawal effects, including nervousness, dizziness, insomnia and even seizures. Reducing doses gradually can prevent this.

_Tolerance. This is when you need more drug to get the same effect and is less likely with the short-acting drugs. Roth co-authored a study that showed that the sleep benefits of a steady dose of Ambien were maintained over eight months of use.

— Risk of early death. A recent study found an association between sleeping pill use and mortality. However, whether the primary contributing factor was pill use could not be determined. For instance, insomnia is also associated with poor health and may play an important role in early death.

"Insomnia is a chronic disorder, and chronic problems require chronic treatment — under supervision," Roth says. "It's worth seeing a doctor who knows the meds and who also knows about behavioral treatments," he adds.

So if your sleep troubles are frequent and persistent, see a doctor — preferably a sleep specialist.

1
Text Only
Community News Network
  • Church's denied request for National Guard visit draws national attention

    A Missouri church finds itself in the middle of a media storm after the Missouri National Guard, citing short notice and time constraints, was not able to fulfill a request last week to appear at the church’s vacation Bible school.

    August 1, 2014

  • 20140727-AMX-GUNS271.jpg Beretta, other gun makers heading to friendlier states

    In moving south and taking 160 jobs with it, Beretta joins several other prominent gunmakers abandoning liberal states that passed tough gun laws after the Newtown shooting.

    August 1, 2014 1 Photo

  • Screen Shot 2014-07-28 at 2.21.22 PM.png VIDEO: Dog 'faints' from excitement of seeing owner

    A reunion between a Pennsylvania woman who had been living overseas for two years and her pet schnauzer has gone viral, garnering nearly 20 million views on YouTube.

    August 1, 2014 1 Photo

  • Why a see-through mouse is a big deal for scientists

    A group of Caltech researchers announced in Cell Thursday their success in making an entire organism transparent. Unfortunately, this isn't any kind of "Invisible Man" scenario: The organism in question is a mouse, and the mouse in question is quite dead.

    July 31, 2014

  • Screen Shot 2014-07-31 at 2.12.55 PM.png VIDEO: Five-year-old doesn't want her brother to grow up

    Sadie, an adorable 5-year-old from Phoenix, wants her brother to stay young forever, so much so that her emotional reaction to the thought of him getting older has drawn more than 10 million views on YouTube.

    July 31, 2014 1 Photo

  • lockport-police.jpg Police department turns to Facebook for guidance on use of 'negro'

    What seems to be a data entry mistake by a small town police department in western New York has turned into a social media firestorm centered around the word "negro" and whether it's acceptable to use in modern society.

    July 31, 2014 3 Photos

  • The virtues of lying

    Two computational scientists set out recently to simulate the effects of lying in a virtual human population. Their results, published in the Proceedings of the Royal Society B, show that lying is essential for the growth of a cohesive social network.

    July 31, 2014

  • Sunburn isn't the only sign of summer that can leave you itchy and blistered

    You've got a rash. You quickly rule out the usual suspects: You haven't been gardening or hiking or even picnicking, so it's probably not a plant irritant such as poison ivy or wild parsnip; likewise, it's probably not chiggers or ticks carrying Lyme disease; and you haven't been swimming in a pond, which can harbor the parasite that causes swimmer's itch.

    July 30, 2014

  • Survey results in legislation to battle sexual assault on campus

    Missouri U.S. Sen. Claire McCaskill joined a bipartisan group of senators Wednesday to announce legislation that aims to reduce the number of sexual assaults on college campuses.

    July 30, 2014

  • An alarming threat to airlines that no one's talking about

    It's been an abysmal year for the flying public. Planes have crashed in bad weather, disappeared over the Indian Ocean and tragically crossed paths with anti-aircraft missiles over Ukraine.

    July 30, 2014

  • Sharknado.jpg Sharknado 2 set to attack viewers tonight

    In the face of another "Sharknado" TV movie (the even-more-inane "Sharknado 2: The Second One," premiering Wednesday night on Syfy), there isn't much for a critic to say except to echo what the characters themselves so frequently scream when confronted by a great white shark spinning toward them in a funnel cloud:
    "LOOK OUT!!"

    July 30, 2014 1 Photo

  • 20140729-AMX-GIVHAN292.jpg Spanx stretches into new territory with jeans, but promised magic is elusive

    The Spanx empire of stomach-flattening, thigh-slimming, jiggle-reducing foundation garments has expanded to include what the brand promises is the mother of all body-shaping miracles: Spanx jeans.

    July 29, 2014 1 Photo

  • Medical marijuana opponents' most powerful argument is at odds with a mountain of research

    Opponents of marijuana legalization are rapidly losing the battle for hearts and minds. Simply put, the public understands that however you measure the consequences of marijuana use, the drug is significantly less harmful to users and society than tobacco or alcohol.

    July 29, 2014

  • linda-ronstadt.jpg Obama had crush on First Lady of Rock

    Linda Ronstadt remained composed as she walked up to claim her National Medal of Arts at a White House ceremony Monday afternoon.

    July 29, 2014 1 Photo

  • Can black women have it all?

    In a powerful new essay for the National Journal, my friend Michel Martin makes a compelling case for why we need to continue the having-it-all conversation.

    July 29, 2014

Obituaries
Featured Ads
Poll

The Iowegian wants readers to think about the solicitation ordinance that will prevent groups or individuals from entering a roadway to solicit money. The Centerville City Council in June by a 5-0 vote passed the first reading of just such an ordinance. Public pressure and during a subsequent special meeting, the council voted 3-2 to table the ordinance. A second special meeting to discuss the solicitation ordinance is scheduled for 5:30 p.m. Thursday, Aug. 7 at City Hall. So, the question of the week is, "Do you or do you not support the ordinance to prevent solicitation of funds in city streets?"

A. I support the ordinance
B. I do not support the ordinance
C. Not sure
     View Results
Iowegian on Facebook